Date: 13 October 2022 - 15 October 2022
Time: 9am – 6pm
Location: Brisbane Convention and Exhibition Centre
Cost:
Access level: Available to everyone
Email: [email protected]
Held jointly with BreastSurgANZ, the Australasian Society for Breast Disease (ASBD) and the 6th World Congress on Controversies in Breast Cancer (CoBrCa) the main congress in the field of breast diseases in the Asia-Pacific region in 2022, it is one that should not be missed!
The Joint Congress will continue the tradition of CoBrCa by directly addressing key issues facing clinicians in their daily practice, including medical oncology, surgery, radiation oncology, breast imaging, pathology, reconstruction, allied health and survivorship issues. The collaboration will create a multi-faceted congress of interest to all involved in the treatment of breast disease and will have a broad national and international faculty.
Through a format of debates, lectures and panel discussions, the congress will provide a forum to effectively address unresolved clinical and therapeutic problems. There will also be a series of workshops and education sessions preceding and during the meeting to address the educational needs of the audience.
We look forward to your participation in this exceptional event.
The AIBC will be a hybrid event, Join us in person or online. Register now for either category with full flexibility to change. Early Registration deadline: Wednesday July 13 2022.
Held jointly with BreastSurgANZ, the Australasian Society for Breast Disease (ASBD) and the 6th World Congress on Controversies in Breast Cancer (CoBrCa) the main congress in the field of breast diseases in the Asia-Pacific region in 2022, it is one that should not be missed!
The Joint Congress will continue the tradition of CoBrCa by directly addressing key issues facing clinicians in their daily practice, including medical oncology, surgery, radiation oncology, breast imaging, pathology, reconstruction, allied health and survivorship issues. The collaboration will create a multi-faceted congress of interest to all involved in the treatment of breast disease and will have a broad national and international faculty.
Through a format of debates, lectures and panel discussions, the congress will provide a forum to effectively address unresolved clinical and therapeutic problems. There will also be a series of workshops and education sessions preceding and during the meeting to address the educational needs of the audience.
We look forward to your participation in this exceptional event.
TOP
